gabapentin has been researched along with baclofen in 79 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.27) | 18.7374 |
| 1990's | 6 (7.59) | 18.2507 |
| 2000's | 30 (37.97) | 29.6817 |
| 2010's | 32 (40.51) | 24.3611 |
| 2020's | 10 (12.66) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Reimann, W | 1 |
| Hill, DR; Suman-Chauhan, N; Webdale, L; Woodruff, GN | 1 |
| Lönnecker, S; Paulus, W; Steinhoff, BJ; Ziemann, U | 1 |
| Averbuch-Heller, L; Büttner, U; Fuhry, L; Ganser, GL; Heide, W; Leigh, RJ; Rottach, KG; Tusa, RJ | 1 |
| Bergler, W; Hein, G; Petroianu, A; Petroianu, G; Rüfer, R | 1 |
| Lorenzo, N; Stringer, JL | 1 |
| Leigh, RJ; Ramat, S | 1 |
| Bergler, W; Hein, G; Petroianu, G; Rüfer, R; Stegmeier-Petroianu, A | 1 |
| Capogna, M; Fox, A; Froestl, W; Kesingland, A; Naeem, S; Patel, S; Urban, L | 1 |
| Krach, LE | 1 |
| Bertrand, S; Chronwall, BM; Lacaille, JC; Low, MJ; Metters, K; Morris, SJ; Ng, GY; Nouel, D; O'Neill, GP; Purisai, MG; Robitaille, R; Severidt, MW; Wolfe, SE | 1 |
| Francisco, GE; Huls, C; Kothari, S | 1 |
| Schapiro, RT | 1 |
| Rösche, J | 1 |
| Fabre, K; Smet-Dieleman, H; Zeyen, T | 1 |
| Bertrand, S; Lacaille, JC; Morin, F | 1 |
| Bertrand, S; Lacaille, JC; Morin, F; Nagy, F; Nouel, D | 1 |
| Enna, SJ | 1 |
| Kerr, DI; Marino, V; Ong, J; Parker, DA | 1 |
| García-Regata, O; González-Macías, J; Hernández, JL; Jiménez, V; Pajarón, M; Ramos-Estébanez, C | 1 |
| Elovic, E; Lombard, L; Zafonte, R | 1 |
| Anagnostouli, M; Karandreas, N; Sarrigiannis, P; Tsakanicas, C | 1 |
| De Vry, J; Jentzsch, KR | 1 |
| Watson, CP | 1 |
| Choudhuri, I; Gottlob, I; Sarvananthan, N | 1 |
| Heinzerling, KG; Ling, W; Liu, J; Peck, JA; Roll, J; Shoptaw, S; Yang, X | 1 |
| Cutrignelli, A; Denora, N; Laquintana, V; Latrofa, A; Liso, G; Lopedota, A; Trapani, A; Trapani, G | 1 |
| Aymon, D; Jichlinski, P; Praz, V; Wisard, M | 1 |
| Hutson, PH; McDonald, LM; Sheppard, WF; Sohal, B; Staveley, SM; Tattersall, FD | 1 |
| Taira, T | 1 |
| Jahn, K; Kalla, R; Rettinger, N; Spiegel, R; Strupp, M; Wagner, J | 1 |
| D'Innocenzo, D; Di Benedetto, G; Grenga, R; Nebbioso, M; Rapone, S | 1 |
| Gottlob, I; McLean, RJ | 1 |
| Kuks, JB; Lapeyre, E; Meijler, WJ | 1 |
| Lagrèze, WA; Pieh-Beisse, C | 1 |
| Blaskiewicz, R; Goldkamp, J; Myles, T | 1 |
| Leigh, RJ; Optican, LM; Shaikh, AG; Thurtell, MJ | 1 |
| Kennard, C; Mehta, AR | 1 |
| Heinzlef, O; Monteil-Roch, I | 1 |
| Cohen, SM; Misono, S | 1 |
| Chen, RX; Hou, XL; Lv, Y; Wu, YL; Xu, XQ; Zhu, Y | 1 |
| Benoliel, R; Haviv, Y; Sharav, Y; Zadik, Y | 1 |
| Bak, K; Bleeker, J; Cavaletti, G; Chauhan, C; Dworkin, RH; Gavin, P; Hershman, DL; Lacchetti, C; Lavino, A; Lavoie Smith, EM; Loprinzi, CL; Lustberg, MB; Paice, J; Schneider, B; Smith, ML; Smith, T; Terstriep, S; Wagner-Johnston, N | 1 |
| Dargan, PI; Green, JL; Kapil, V; Le Lait, MC; Wood, DM | 1 |
| Fox, M; Schneemann, M; Steger, M | 1 |
| Banov, D; Bassani, AS | 1 |
| Trojano, M | 1 |
| Comi, G; Gold, R; Hartung, HP; Montalban, X; Otero-Romero, S; Sastre-Garriga, J; Soelberg Sørensen, P; Thompson, AJ; Vermersch, P | 1 |
| Andrews, R; Nahar, L; Patel, R; Paterson, S; Smith, A | 1 |
| Lyon, J | 1 |
| Bardenheuer, HJ; Hollmann, MW; Kessler, J; Kohse, EK | 1 |
| Harvey, A; Reddihough, D; Scheinberg, A; Williams, K | 1 |
| Dodridge, CS; Evans, JR; Garcia-Finana, M; Hanna, K; Howard, C; Jarvis, KA; Maan, T; MacDiarmid, SL; Noonan, CP; North, L; Rodgers, H; Rowe, FJ | 1 |
| Ahmad, SU; Kumar, J; Mohamed, IN; Pakri Mohamed, RM | 1 |
| Amato, L; Amin-Esmaeili, M; Gholami, J; Hoseinie, L; Rahimi-Movaghar, A; Yousefi-Nooraie, R | 1 |
| Cruccu, G; Di Stefano, G; Truini, A | 1 |
| Dorsey, SG; Griffioen, MA; O'Toole, RV; Renn, CL; Ziegler, ML | 1 |
| Hiremath, S; Sriperumbuduri, S | 1 |
| Chen, Q; Ding, H; Dong, R; Lv, H; Pan, J; Qiu, Z; Shi, C; Xu, X; Yu, L; Yu, Y; Zhang, M | 1 |
| Alho, H; Castrén, S; Mäkelä, N | 1 |
| Dong, R; Qiu, Z; Xu, X; Yu, L | 1 |
| Naik, RD; Vaezi, MF | 1 |
| Yuan, SM | 1 |
| Aletraris, L; Paino, M; Roman, PM | 1 |
| Centonze, D; Comi, G; Leocani, L; Otero-Romero, S; Solari, A | 1 |
| Hughes, P; Ostrach, B | 1 |
| Murphy, KG; Nahar, LK; Paterson, S | 1 |
| Barnett, ML; Bykov, K; Gagne, JJ; Glynn, RJ; Khan, NF | 1 |
| Alizadeh-Sani, M; Foroumadi, A; Hasanvand, Z; Jouyban, A; Mohammadian, E; Rahimpour, E | 1 |
| Davis, JF; Mata, DC | 1 |
| Fomin, V; Goodman, RP; Luther, J; Patel, SJ; Schaefer, E; Shay, JES; Vannier, AGL | 1 |
| Dahal, S; Khati, N; Maharjan, G; Yadav, P; Yadav, SK | 1 |
| Chen, J; Guo, X; Jiang, B; Liang, B; Wang, W | 1 |
29 review(s) available for gabapentin and baclofen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Neuropharmacologic aspects of the ocular motor system and the treatment of abnormal eye movements.
Topics: Abducens Nerve; Acetates; Amines; Baclofen; Cranial Nerve Diseases; Cyclohexanecarboxylic Acids; Eye Movements; Fixation, Ocular; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypoglossal Nerve; Ocular Motility Disorders; Vestibular Nerve; Visual Pathways | 1999 |
Pharmacotherapy of spasticity: oral medications and intrathecal baclofen.
Topics: Acetates; Administration, Oral; Amines; Anti-Anxiety Agents; Baclofen; Benzodiazepines; Cerebral Palsy; Child, Preschool; Cyclohexanecarboxylic Acids; Dantrolene; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Injections, Spinal; Muscle Relaxants, Central | 2001 |
GABA agonists and gabapentin for spastic hypertonia.
Topics: Acetates; Amines; Animals; Anticonvulsants; Baclofen; Benzodiazepines; Cyclohexanecarboxylic Acids; Diazepam; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Muscle Spasticity | 2001 |
Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.
Topics: Acetates; Amines; Autoimmune Diseases; Baclofen; Benzodiazepines; Botulinum Toxins, Type A; Cannabinoids; Causalgia; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Dystonia; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Mechanoreceptors; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Pain; Physical Therapy Modalities; Receptors, GABA-A; Receptors, GABA-B; Relaxation Therapy; Trigeminal Neuralgia | 2001 |
A GABA(B) mystery: the search for pharmacologically distinct GABA(B) receptors.
Topics: Acetates; Amines; Animals; Anticonvulsants; Baclofen; Benzylamines; Cyclohexanecarboxylic Acids; GABA Agonists; GABA Antagonists; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Molecular Structure; Morpholines; Phosphinic Acids; Protein Isoforms; Receptors, GABA-B; RNA, Messenger | 2001 |
Gabapentin for intractable hiccup.
Topics: Acetates; Aged; Amines; Baclofen; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Guillain-Barre Syndrome; Hiccup; Humans; Male; Muscle Relaxants, Central; Tomography, X-Ray Computed | 2004 |
Antispasticity medications: uses and limitations of enteral therapy.
Topics: 4-Aminopyridine; Acetates; Adrenergic alpha-Agonists; Amines; Baclofen; Benzodiazepines; Cyclohexanecarboxylic Acids; Cyproheptadine; Dantrolene; Dronabinol; Gabapentin; gamma-Aminobutyric Acid; Glycine; Humans; Muscle Relaxants, Central; Muscle Spasticity; Neuroprotective Agents; Piracetam; Serotonin Antagonists | 2004 |
Management issues of neuropathic trigeminal pain from a medical perspective.
Topics: Amines; Analgesics, Non-Narcotic; Anticonvulsants; Antidepressive Agents; Baclofen; Carbamazepine; Cranial Nerve Injuries; Cyclohexanecarboxylic Acids; Facial Neuralgia; Facial Pain; Gabapentin; gamma-Aminobutyric Acid; Herpes Zoster; Humans; Lamotrigine; Narcotics; Phenytoin; Triazines; Trigeminal Nerve Injuries; Trigeminal Neuralgia | 2004 |
[Chronic intrathecal drug administration for the control of intractable pain].
Topics: Amines; Analgesics, Opioid; Anesthetics, Local; Baclofen; Calcium Channel Blockers; Clonidine; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Infusion Pumps, Implantable; Injections, Spinal; Morphine; Neoplasms; Neuralgia; omega-Conotoxins; Pain, Intractable | 2008 |
[Pharmacotherapy of central oculomotor disorders].
Topics: 4-Aminopyridine; Amifampridine; Amines; Baclofen; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Gabapentin; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Imaging; Memantine; Nystagmus, Pathologic; Vestibular Nuclei | 2008 |
[Nystagmus in ophthalmology].
Topics: Amines; Baclofen; Cyclohexanecarboxylic Acids; Diagnostic Techniques, Ophthalmological; Eye Diseases; Gabapentin; gamma-Aminobutyric Acid; Humans; Nervous System Diseases; Nystagmus, Pathologic; Nystagmus, Physiologic; Ophthalmologic Surgical Procedures | 2009 |
The pharmacological treatment of nystagmus: a review.
Topics: Amines; Animals; Baclofen; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Memantine; Nystagmus, Congenital; Nystagmus, Pathologic; Randomized Controlled Trials as Topic | 2009 |
Spasticity: revisiting the role and the individual value of several pharmacological treatments.
Topics: Amines; Baclofen; Botulinum Toxins; Calcium Channel Blockers; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Diazepam; Gabapentin; gamma-Aminobutyric Acid; Humans; Muscle Relaxants, Central; Muscle Spasticity; Recovery of Function; Treatment Outcome | 2010 |
The pharmacological treatment of acquired nystagmus.
Topics: Amines; Aminopyridines; Baclofen; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Memantine; Nystagmus, Congenital; Nystagmus, Pathologic; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
[Pharmacological treatment of spasticity in multiple sclerosis].
Topics: Algorithms; Amines; Baclofen; Botulinum Toxins, Type A; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Double-Blind Method; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Humans; Infusion Pumps, Implantable; Injections, Spinal; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Nerve Block; Neuromuscular Agents; Randomized Controlled Trials as Topic; Spasm; Vigabatrin | 2012 |
Use of specific neuromodulators in the treatment of chronic, idiopathic cough: a systematic review.
Topics: Amines; Amitriptyline; Baclofen; Chronic Disease; Cough; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Neurotransmitter Agents; Pregabalin; Quality of Life | 2013 |
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Topics: Adult; Amines; Amitriptyline; Analgesics; Anticonvulsants; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Baclofen; Comorbidity; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Duloxetine Hydrochloride; Evidence-Based Medicine; Gabapentin; gamma-Aminobutyric Acid; Gels; Humans; Incidence; Ketamine; Neoplasms; Neuralgia; Peripheral Nervous System Diseases; Quality of Life; Randomized Controlled Trials as Topic; Severity of Illness Index; Survivors; Thiophenes; Treatment Outcome; United States | 2014 |
Systemic review: the pathogenesis and pharmacological treatment of hiccups.
Topics: Amines; Anticonvulsants; Antipsychotic Agents; Baclofen; Benzamides; Chlorpromazine; Cyclohexanecarboxylic Acids; GABA-B Receptor Agonists; Gabapentin; gamma-Aminobutyric Acid; Hiccup; Humans; Metoclopramide; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Topics: Amines; Analgesics; Baclofen; Cannabidiol; Clonidine; Cyclohexanecarboxylic Acids; Dantrolene; Diazepam; Dronabinol; Drug Combinations; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Injections, Spinal; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Phenol | 2016 |
Chronic Hiccups: An Underestimated Problem.
Topics: Amines; Anesthesiology; Baclofen; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Hiccup; Humans; Muscle Relaxants, Central | 2017 |
Interventions for eye movement disorders due to acquired brain injury.
Topics: 4-Aminopyridine; Abducens Nerve Diseases; Amifampridine; Amines; Baclofen; Botulinum Toxins; Brain Injuries; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuromuscular Agents; Nystagmus, Pathologic; Ocular Motility Disorders; Randomized Controlled Trials as Topic; Vision, Binocular; Watchful Waiting | 2018 |
Novel Pharmacotherapeutic Approaches in Treatment of Alcohol Addiction.
Topics: Alcohol Deterrents; Alcoholism; Animals; Aripiprazole; Baclofen; Cyclopentanes; Gabapentin; Humans; Naltrexone; Quetiapine Fumarate | 2018 |
Pharmacological therapies for management of opium withdrawal.
Topics: Amantadine; Amines; Baclofen; Buprenorphine; Clonidine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Methadone; Opioid-Related Disorders; Opium; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Tramadol | 2018 |
Current and Innovative Pharmacological Options to Treat Typical and Atypical Trigeminal Neuralgia.
Topics: Anticonvulsants; Antidepressive Agents; Baclofen; Carbamazepine; Drug Therapy, Combination; Gabapentin; Humans; Lamotrigine; Oxcarbazepine; Phenyl Ethers; Proline; Sodium Channel Blockers; Trigeminal Neuralgia | 2018 |
The case for cautious consumption: NSAIDs in chronic kidney disease.
Topics: Acute Kidney Injury; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Baclofen; Cost-Benefit Analysis; Gabapentin; Humans; Pain; Pregabalin; Renal Insufficiency, Chronic; Tramadol | 2019 |
Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
Topics: Acamprosate; Alcoholism; Antidepressive Agents; Baclofen; Cholinergic Agonists; Disulfiram; Gabapentin; Humans; Naltrexone; Ondansetron; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Myocardial Ischemia Presenting with Hiccups.
Topics: Baclofen; Electrocardiography; GABA-B Receptor Agonists; Gabapentin; Hiccup; Humans; Myocardial Infarction; Myocardial Ischemia; Treatment Outcome | 2019 |
Derivatization of γ-Amino Butyric Acid Analogues for Their Determination in the Biological Samples and Pharmaceutical Preparations: A Comprehensive Review.
Topics: Anticonvulsants; Baclofen; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Pharmaceutical Preparations; Pregabalin; Vigabatrin | 2022 |
3 trial(s) available for gabapentin and baclofen
| Article | Year |
|---|---|
A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.
Topics: Acetates; Adult; Aged; Amines; Anticonvulsants; Baclofen; Cyclohexanecarboxylic Acids; Double-Blind Method; Eye Movements; Female; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Nystagmus, Pathologic; Treatment Outcome; Visual Acuity | 1997 |
Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence.
Topics: Adult; Amines; Anti-Anxiety Agents; Baclofen; Central Nervous System Stimulants; Cyclohexanecarboxylic Acids; Demography; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Methamphetamine; Psychology; Substance-Related Disorders; Surveys and Questionnaires | 2006 |
Randomised clinical trial: gabapentin vs baclofen in the treatment of suspected refractory gastro-oesophageal reflux-induced chronic cough.
Topics: Adult; Analgesics; Baclofen; Chronic Disease; Cough; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gabapentin; Gastroesophageal Reflux; Humans; Male; Middle Aged; Muscle Relaxants, Central; Treatment Outcome | 2019 |
47 other study(ies) available for gabapentin and baclofen
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action?
Topics: Acetates; Amines; Animals; Baclofen; Bicuculline; Binding Sites; Caudate Nucleus; Cyclohexanecarboxylic Acids; Dopamine; Female; Gabapentin; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Nipecotic Acids; Rabbits | 1983 |
Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies.
Topics: Acetates; Amines; Amino Acids; Animals; Anticonvulsants; Baclofen; Binding Sites; Cell Membrane; Cerebral Cortex; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Hydrogen-Ion Concentration; Rats; Receptors, GABA-A; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Spermidine; Spermine | 1993 |
Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.
Topics: 4-Aminobutyrate Transaminase; Acetates; Adult; Amines; Anticonvulsants; Baclofen; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Differential Threshold; Enzyme Inhibitors; Gabapentin; gamma-Aminobutyric Acid; Humans; Motor Cortex; Physical Stimulation; Transcranial Magnetic Stimulation; Vigabatrin | 1996 |
[ETICS Study: Empirical therapy of idiopathic chronic singultus].
Topics: Acetates; Aged; Aged, 80 and over; Amines; Baclofen; Chronic Disease; Cisapride; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Gastrointestinal Agents; Hiccup; Humans; Male; Middle Aged; Omeprazole; Treatment Outcome | 1998 |
The reduction in paired-pulse inhibition in the rat hippocampus by gabapentin is independent of GABA(B) receptor receptor activation.
Topics: Acetates; Amines; Animals; Anticonvulsants; Baclofen; Cyclohexanecarboxylic Acids; Dentate Gyrus; Electric Stimulation; GABA Agonists; GABA Antagonists; Gabapentin; gamma-Aminobutyric Acid; Male; Neural Inhibition; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Receptors, GABA-B | 1999 |
Gabapentin "add-on therapy" for idiopathic chronic hiccup (ICH).
Topics: Acetates; Aged; Amines; Baclofen; Chronic Disease; Cisapride; Cyclohexanecarboxylic Acids; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Gastrointestinal Agents; Hiccup; Humans; Male; Middle Aged; Muscle Relaxants, Central; Omeprazole; Treatment Outcome | 2000 |
The effects of GABA(B) agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat.
Topics: Acetates; Amines; Analgesics; Animals; Baclofen; Cyclohexanecarboxylic Acids; Electric Stimulation; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; In Vitro Techniques; Inflammation; Neuralgia; Rats; Rats, Wistar; Spinal Nerve Roots | 2001 |
The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels.
Topics: Acetates; Amines; Analgesics; Animals; Anticonvulsants; Baclofen; Calcium Channels; Calcium Signaling; Cyclohexanecarboxylic Acids; GABA Agonists; GABA-B Receptor Agonists; Gabapentin; gamma-Aminobutyric Acid; Hippocampus; Male; Mice; Mice, Transgenic; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, GABA-B | 2001 |
Treatment of spasticity.
Topics: Acetates; Amines; Aminopyridines; Baclofen; Benzodiazepines; Botulinum Toxins, Type A; Clonidine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Memantine; Muscle Spasticity; Paralysis; Rhizotomy | 2002 |
Improvement of acquired pendular nystagmus by gabapentin: case report.
Topics: Acetates; Administration, Oral; Amines; Baclofen; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Middle Aged; Multiple Sclerosis; Nystagmus, Pathologic; Treatment Outcome | 2001 |
Different actions of gabapentin and baclofen in hippocampus from weaver mice.
Topics: Acetates; Amines; Animals; Baclofen; Cyclohexanecarboxylic Acids; Down-Regulation; Excitatory Amino Acid Antagonists; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Hippocampus; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Neurologic Mutants; Neural Inhibition; Organ Culture Techniques; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyramidal Cells; Receptors, GABA-B; Species Specificity; Synaptic Transmission | 2003 |
Gabapentin actions on Kir3 currents and N-type Ca2+ channels via GABAB receptors in hippocampal pyramidal cells.
Topics: Acetates; Action Potentials; Amines; Animals; Anticonvulsants; Baclofen; Barium; Calcium Channel Blockers; Calcium Channels, N-Type; Cell Membrane; Cesium; Cyclohexanecarboxylic Acids; Epilepsy; Ethylmaleimide; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gabapentin; gamma-Aminobutyric Acid; GTP-Binding Proteins; Hippocampus; Male; omega-Conotoxin GVIA; Organ Culture Techniques; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, GABA-B | 2003 |
Gabapentin activates presynaptic GABAB heteroreceptors in rat cortical slices.
Topics: Amines; Animals; Baclofen; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; In Vitro Techniques; Male; Morpholines; Neocortex; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Receptors, Presynaptic; Tritium | 2004 |
Spastic paretic hemifacial contracture (SPHC) in a patient with multiple sclerosis. A clinical, EMG and neuroimaging study.
Topics: Adult; Amines; Baclofen; Blinking; Brain; Clonazepam; Cyclohexanecarboxylic Acids; Electromyography; Evoked Potentials; Excitatory Amino Acid Antagonists; Facial Muscles; Female; GABA Agonists; GABA Modulators; Gabapentin; gamma-Aminobutyric Acid; Hemifacial Spasm; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Neurons; Pons | 2004 |
Discriminative stimulus effects of the structurally novel cannabinoid CB1/CB2 receptor partial agonist BAY 59-3074 in the rat.
Topics: Alkanesulfonates; Amines; Amitriptyline; Animals; Baclofen; Behavior, Animal; Benzoxazines; Carbamazepine; Cyclohexanecarboxylic Acids; Cyclohexanols; Discrimination Learning; Dose-Response Relationship, Drug; Dronabinol; Gabapentin; gamma-Aminobutyric Acid; Indans; Male; Molecular Structure; Morphine; Morpholines; Naphthalenes; Nitriles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sulfonic Acids | 2004 |
Survey of management of acquired nystagmus in the United Kingdom.
Topics: Amines; Baclofen; Cyclohexanecarboxylic Acids; Drug Utilization; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Health Care Surveys; Humans; Multiple Sclerosis; Neoplasms; Neurology; Nystagmus, Pathologic; Ophthalmology; Professional Practice; Referral and Consultation; Stroke; Treatment Outcome; United Kingdom; Vestibular Diseases | 2007 |
Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations.
Topics: Amines; Anticonvulsants; Baclofen; beta-Cyclodextrins; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cyclohexanecarboxylic Acids; Drug Stability; Excipients; Freeze Drying; Gabapentin; gamma-Aminobutyric Acid; Humidity; Kinetics; Lactams; Lactose; Mannitol; Models, Chemical; Molecular Structure; Parasympatholytics; Povidone; Raffinose; Technology, Pharmaceutical; Temperature; Thermogravimetry; Trehalose; Water | 2007 |
A case report on idiopathic recurrent priapism.
Topics: Adult; Amines; Androgen Antagonists; Baclofen; Cyclohexanecarboxylic Acids; Cyproterone Acetate; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Muscle Relaxants, Central; Priapism; Secondary Prevention | 2007 |
Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats.
Topics: Administration, Oral; Amines; Animals; Anticonvulsants; Azabicyclo Compounds; Baclofen; Benzodiazepines; Bicuculline; Brain; Cyclohexanecarboxylic Acids; Discrimination Learning; Dose-Response Relationship, Drug; GABA Agents; GABA Agonists; GABA Antagonists; GABA Plasma Membrane Transport Proteins; Gabapentin; gamma-Aminobutyric Acid; Generalization, Stimulus; Hypnotics and Sedatives; Injections, Intraperitoneal; Isoxazoles; Male; Nipecotic Acids; Piperazines; Pyridines; Rats; Thiophenes; Tiagabine; Zolpidem | 2008 |
[Pharmacological treatment of nystagmus].
Topics: 4-Aminopyridine; Amines; Anticonvulsants; Baclofen; Cyclohexanecarboxylic Acids; Dopamine Agents; Gabapentin; gamma-Aminobutyric Acid; Humans; Memantine; Muscle Relaxants, Central; Nystagmus, Pathologic; Potassium Channel Blockers | 2011 |
Stiff person syndrome and pregnancy.
Topics: Adult; Amines; Baclofen; Cesarean Section; Cyclohexanecarboxylic Acids; Diazepam; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Infant, Newborn; Muscle Relaxants, Central; Prednisone; Pregnancy; Spasm; Stiff-Person Syndrome; Treatment Outcome | 2011 |
Pharmacological tests of hypotheses for acquired pendular nystagmus.
Topics: Amines; Baclofen; Cerebellar Cortex; Cyclohexanecarboxylic Acids; Eye Movements; Gabapentin; gamma-Aminobutyric Acid; Humans; Memantine; Models, Neurological; Multiple Sclerosis; Myoclonus; Nystagmus, Pathologic; Olivary Nucleus | 2011 |
Evaluation of two modified quick, easy, cheap, effective, rugged and safe (QuEChERS) sample preparation methods for the analysis of baclofen and gabapentin in feeds by liquid chromatography tandem mass spectrometry.
Topics: Acetonitriles; Amines; Animal Feed; Baclofen; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography, Liquid; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Formates; GABA-B Receptor Agonists; Gabapentin; gamma-Aminobutyric Acid; Mass Spectrometry; Methanol; Reproducibility of Results; Time Factors; Water | 2014 |
Painful traumatic trigeminal neuropathy: an open study on the pharmacotherapeutic response to stepped treatment.
Topics: Amines; Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Baclofen; Carbamazepine; Clinical Protocols; Cohort Studies; Cyclohexanecarboxylic Acids; Drug Combinations; Duloxetine Hydrochloride; Female; Follow-Up Studies; GABA-B Receptor Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Medical Records; Middle Aged; Nortriptyline; Pain; Pain Measurement; Pregabalin; Prognosis; Prospective Studies; Thiophenes; Treatment Outcome; Trigeminal Nerve Injuries; Trigeminal Neuralgia | 2014 |
Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK.
Topics: Adolescent; Adult; Amines; Baclofen; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Health Surveys; Humans; Illicit Drugs; Male; Middle Aged; Pregabalin; Prescription Drug Misuse; United Kingdom; Young Adult | 2014 |
Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model.
Topics: Administration, Cutaneous; Aged; Amines; Baclofen; Clonidine; Cyclohexanecarboxylic Acids; Drug Compounding; Drug Evaluation, Preclinical; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Male; Middle Aged; Organ Culture Techniques; Pain; Skin Absorption | 2016 |
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
Topics: Adult; Amines; Baclofen; Calcium Channel Blockers; Cannabidiol; Cohort Studies; Cyclohexanecarboxylic Acids; Dronabinol; Drug Combinations; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Germany; Humans; Italy; Male; Medical Marijuana; Middle Aged; Multiple Sclerosis; Muscle Relaxants, Central; Muscle Spasticity; Observational Studies as Topic; Oral Sprays; Plant Extracts; Pregabalin; Prospective Studies; Treatment Outcome | 2016 |
Validated Method for the Screening and Quantification of Baclofen, Gabapentin and Pregabalin in Human Post-Mortem Whole Blood Using Protein Precipitation and Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Amines; Autopsy; Baclofen; Chemical Precipitation; Chromatography, High Pressure Liquid; Chromatography, Liquid; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Pregabalin; Reproducibility of Results; Tandem Mass Spectrometry | 2017 |
More Treatments on Deck for Alcohol Use Disorder.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Amines; Baclofen; Cyclohexanecarboxylic Acids; Cytidine Diphosphate Choline; Disulfiram; Drug Repositioning; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Mifepristone; Naltrexone; National Institute on Alcohol Abuse and Alcoholism (U.S.); Off-Label Use; Patient Acceptance of Health Care; Taurine; Topiramate; United States; Varenicline | 2017 |
Oral medication prescription practices of tertiary-based specialists for dystonia in children with cerebral palsy.
Topics: Administration, Oral; Adolescent; Australia; Baclofen; Central Nervous System Agents; Cerebral Palsy; Child; Child, Preschool; Cross-Sectional Studies; Dystonia; Gabapentin; Health Care Surveys; Humans; Infant; Muscle Relaxants, Central; Practice Patterns, Physicians'; Tertiary Care Centers | 2018 |
Change in Pain Score after Administration of Analgesics for Lower Extremity Fracture Pain during Hospitalization.
Topics: Adult; Amitriptyline; Analgesics; Anticonvulsants; Antidepressive Agents; Baclofen; Bones of Lower Extremity; Cohort Studies; Duloxetine Hydrochloride; Female; Fractures, Bone; Gabapentin; Hospitalization; Humans; Male; Middle Aged; Muscle Relaxants, Central; Pain Management; Pain Measurement; Pregabalin; Retrospective Studies | 2019 |
Editorial: breaking the cycle of cough in GERD-neuromodulators to the rescue? Authors' reply.
Topics: Baclofen; Cough; Gabapentin; Gastroesophageal Reflux; Humans; Neurotransmitter Agents | 2019 |
Editorial: breaking the cycle of cough in GERD-neuromodulators to the rescue?
Topics: Baclofen; Cough; Gabapentin; Gastroesophageal Reflux; Humans; Neurotransmitter Agents | 2019 |
The use of off-label medications in substance abuse treatment programs.
Topics: Accreditation; Adrenergic alpha-2 Receptor Agonists; Anticonvulsants; Antiemetics; Baclofen; Clonidine; Excitatory Amino Acid Antagonists; GABA Agents; Gabapentin; Health Facility Size; Humans; Logistic Models; Off-Label Use; Ondansetron; Practice Patterns, Physicians'; Substance Abuse Treatment Centers; Substance-Related Disorders; Time Factors; Topiramate; United States; Valproic Acid | 2020 |
Italian consensus on treatment of spasticity in multiple sclerosis.
Topics: Baclofen; Botulinum Toxins; Clonidine; Consensus; Disease Management; Gabapentin; Humans; Injections, Intramuscular; Italy; Multiple Sclerosis; Muscle Spasticity; Quality of Life; Transcutaneous Electric Nerve Stimulation | 2020 |
Trends in exposure to over-reach: a comment on the methodology of Reynolds et al. 2019.
Topics: Baclofen; Gabapentin; Humans; Poisons | 2021 |
Baclofen: To Screen or Not to Screen in Postmortem Blood?
Topics: Autopsy; Baclofen; Gabapentin; Humans; Pregabalin; Substance-Related Disorders | 2021 |
Coprescription of Opioids With Other Medications and Risk of Opioid Overdose.
Topics: Adult; Aged; Analgesics, Opioid; Baclofen; Benzodiazepines; Drug Interactions; Emergency Service, Hospital; Excitatory Amino Acid Antagonists; Female; Gabapentin; Hospitalization; Humans; Hypnotics and Sedatives; Lorazepam; Male; Middle Aged; Muscle Relaxants, Central; Opiate Overdose; Risk Factors | 2021 |
Simultaneous quantitative analysis of 39 common toxicological drugs for increased efficiency in an ante- and postmortem laboratory.
Topics: Baclofen; Chromatography, High Pressure Liquid; Forensic Toxicology; Gabapentin; Pregabalin; Reproducibility of Results | 2022 |
Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder.
Topics: Alcoholism; Baclofen; Female; Gabapentin; Humans; Incidence; Liver Cirrhosis; Male; Middle Aged; Naltrexone; Retrospective Studies; Topiramate | 2022 |
Status Dystonicus with Atypical Presentation in Developmentally Delay Child: A Case Report.
Topics: Baclofen; Child; Child, Preschool; Dystonia; Dystonic Disorders; Female; Gabapentin; Humans; Seizures | 2022 |
Treatment of severe tardive dyskinesia with concurrent administration of olanzapine, clonazepam, baclofen, and gabapentin: a case report.
Topics: Adolescent; Antipsychotic Agents; Baclofen; Clonazepam; Female; Gabapentin; Humans; Olanzapine; Tardive Dyskinesia | 2023 |